Diabetes Relief LLC is pleased to announce that Brian Loveridge, M.D., has been named its new Chief Medical Officer for the entire operation. Dr. Loveridge replaces Stanley T. Lewis, Jr., M.D., who has served Diabetes Relief so well since 2016 in developing its patented and patent-pending treatment for metabolic disorder. Dr. Lewis is named Senior Medical Advisor and will continue to serve on the company’s Medical Advisory Board as he is becoming more involved in international pursuits with his other medical and business interests. Dr. Loveridge will continue to serve as Medical Director for the Utah facility, and he will continue his very important work with Diabetes Relief’s training and educational sessions for licensees.

Pin It on Pinterest